Fig. 6
From: DOCK1 regulates the malignant biological behavior of endometrial cancer through c-Raf/ERK pathway
DOCK1 regulated cell viability, migration, invasion and apoptosis via c-RAF/ERK signaling pathway. (A) The efficacy of Raf inhibitor LY3009120 on Ishikawa cells. (B) The effect of LY3009120 on the viability of DOCK1-overpressing Ishikawa cells. (C) The effect of LY3009120 on the cell migration and invasion of cells after DOCK1 overexpression. (D) The effect of LY3009120 on the apoptosis of DOCK1-overexpressing Ishikawa cells. *P < 0.05